Launched in 2022, Texas Biologics is a translational research Center focused on the discovery, early development and clinical translation of biologic therapies. Led by the Cockrell School of Engineering and the College of Natural Sciences, Texas Biologics formalizes the incredible work UT Austin researchers have been doing in biologics for years. It is a collaborative initiative, engaging researchers from across campus–from Dell Medical School to the College of Pharmacy to the Machine Learning Laboratory.
Our Mission
To develop groundbreaking biologic therapies that can rapidly move from discovery to clinical development and regulatory approval, thus making lasting contributions to human health and improving quality of life.
Our Vision
To become a world-recognized leader and educator in the development of biologics.
Our Disease Focus Areas
- Infectious Diseases
- Aging/Neurodegeneration
- Cancer
- Inborn Errors of Metabolism/Orphan Diseases
Our Technologies
- Pioneered structure-based design of the active component in vaccines
- World leader in molecular serum antibody deconvolution to identify antibodies for drug targets
